Systemic Lupus Erythematosus News

• Subcutaneous Belimumab Improves Systemic Lupus Erythematosus Outcomes
  Reuters Health Information, April 2018
• Germany's Merck Seeks Partners for Cancer and Immune System Drugs Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
  Reuters Health Information, April 2018
• Epstein-Barr Virus Transcription Factor Implicated in Seven Autoimmune Diseases
  Reuters Health Information, April 2018
• Patient Advocacy Groups Take in Millions From Drugmakers. Is There Payback? Kaiser Health News launches 'Pre$cription for Power,' a groundbreaking database to expose Big Pharma’s ties to patient groups.
  Kaiser Health News, April 2018
• ENDO 2018Adult-Onset Type 1 Diabetes, Other Autoimmune Diseases Linked The risk of developing additional autoimmune conditions rises with age of type 1 diabetes onset.
  Medscape Medical News, March 2018
• Biologics in Pregnancy Safe, Pose No Preterm or SGA Risk Previous studies finding a link between biologics exposure and preterm birth or SGA did not adequately account for potential confounders, researchers note.
  Medscape Medical News, March 2018
• Off-label Lenalidomide Might Be Alternative to Thalidomide for Erythema Multiforme Lenalidomide might be considered as off-label treatment for chronic erythema multiforme (EM) if the adverse effects of thalidomide are not acceptable, according to French researchers.
  Reuters Health Information, March 2018
• Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes Synovial gene expression and histology can be used to divide rheumatoid arthritis (RA) into high, low, and mixed inflammatory subtypes, according to results from the Accelerating Medicine Partnership: RA/SLE Network.
  Reuters Health Information, March 2018
• AstraZeneca Spins Off Autoimmune Drugs Into New Biotech Company AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.
  Reuters Health Information, February 2018
• Doctors Learn How to Talk to Patients About Dying Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
  Kaiser Health News, February 2018
• Cancer Immunotherapy May Be Safe for Rheumatology Patients A minority of those who received immune checkpoint inhibitors and had underlying rheumatologic disease experienced flare-ups or adverse effects, a small study found.
  Medscape Medical News, January 2018
• Rheumatoid Arthritis May Confer Higher Cardiac and Infection Risks Patients with rheumatoid arthritis (RA) are at increased risk of serious infections, myocardial infarction (MI), and coronary heart disease (CHD), an analysis of Medicare claims data suggests.
  Reuters Health Information, January 2018
• Alert Self-injectable Belimumab for SLE Approved in Europe With training, patients with SLE can administer the new subcutaneous formulation as a once-weekly injection from a single-dose prefilled syringe or from a single-dose autoinjector.
  International Approvals, November 2017
• ACRNew ACR, EULAR Criteria Distinguish Lupus From Imitators Researchers from around the world contributed to the development of classification criteria for systemic lupus erythematosus (SLE) designed to distinguish the autoimmunity from common mimickers.
  Medscape Medical News, November 2017
• Lupus-Related Mortality Has Declined, but Gap Remains Systemic lupus erythematosus deaths have declined during the last half-century, but the gains have not been uniform across subpopulations, researchers reported.
  Medscape Medical News, October 2017
• ACRTrial Probes Flu Shots in the Immunocompromised A highly anticipated clinical trial to be presented at the upcoming American College of Rheumatology meeting will help clinicians make decisions about vaccinating patients with immune disorders.
  Medscape Medical News, October 2017
• New SLE Guideline Aims to Improve Diagnosis, Reduce Steroids The British Society for Rheumatology issued the first comprehensive guideline for management of systemic lupus erythematosus in adults.
  Medscape Medical News, October 2017
• Alert Belimumab (Benlysta) Cleared in Japan for Lupus Belimumab is now approved in Japan for the treatment of adults with active, autoantibody-positive systemic lupus erythematosus who do not respond adequately to existing therapies.
  International Approvals, September 2017
• Lupus Incidence, Prevalence Differ by Race Racial and ethnic disparities in systemic lupus erythematosus (SLE) incidence and prevalence are considerable, according to two new studies of data from California and Manhattan.
  Reuters Health Information, September 2017
• Alert EU Regulators Approve Self-injectable Belimumab for Lupus The new version of belimumab can spare patients with systemic lupus erythematosus the need to have an intravenous infusion of the drug at a hospital or clinic.
  International Approvals, September 2017